MRE11 Gene Ataxia Telangiectasia Like Disorder NGS Genetic DNA Test
Comprehensive Genetic Testing for Neurological Disorders
The MRE11 Gene Ataxia Telangiectasia Like Disorder NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise identification of mutations in the MRE11 gene that cause Ataxia Telangiectasia Like Disorder (ATLD). This rare autosomal recessive condition shares clinical features with Ataxia Telangiectasia but involves distinct genetic pathways and manifestations.
What This Advanced Genetic Test Measures
Our comprehensive NGS-based test specifically targets the MRE11 gene, which plays a critical role in DNA damage repair and cellular stability. The test detects:
- Point mutations and small insertions/deletions in the MRE11 gene
- Copy number variations affecting gene function
- Pathogenic variants associated with ATLD development
- Carrier status for family planning purposes
Who Should Consider This Genetic Test
This specialized neurological genetic test is recommended for individuals presenting with:
- Progressive cerebellar ataxia beginning in childhood
- Oculomotor apraxia and coordination difficulties
- Family history of neurological disorders resembling ATLD
- Unexplained developmental delays with neurological symptoms
- Increased sensitivity to radiation therapy
- Suspected DNA repair deficiency disorders
Key Benefits of MRE11 Genetic Testing
- Early Diagnosis: Enables timely intervention and management strategies
- Family Planning: Provides crucial information for genetic counseling and reproductive decisions
- Personalized Care: Guides targeted treatment approaches based on genetic findings
- Risk Assessment: Identifies cancer predisposition and other associated health risks
- Definitive Answers: Resolves diagnostic uncertainty for complex neurological presentations
Understanding Your Test Results
Our comprehensive genetic counseling support helps you interpret your results:
- Positive Result: Indicates presence of pathogenic MRE11 mutations requiring specialized neurological care
- Negative Result: Suggests ATLD is unlikely, though other genetic conditions may need consideration
- Variant of Uncertain Significance: Requires ongoing monitoring and potential family studies
- Carrier Status: Important information for family planning and genetic counseling
Test Details and Pricing
| Test Component | Details |
|---|---|
| Test Name | MRE11 Gene Ataxia Telangiectasia Like Disorder NGS Genetic DNA Test |
| Regular Price | $700 USD |
| Discount Price | $500 USD |
| Turnaround Time | 3-4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next Generation Sequencing (NGS) Technology |
Pre-Test Requirements
To ensure optimal testing outcomes, we require:
- Complete clinical history of the patient
- Genetic counseling session to create detailed family pedigree
- Documentation of neurological symptoms and progression
- Informed consent for genetic testing
Nationwide Accessibility
We have diagnostic centers conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures accessible genetic testing services regardless of your location.
Take Control of Your Neurological Health
Don’t let uncertainty about neurological symptoms affect your quality of life. Our MRE11 genetic test provides the clarity needed for proper diagnosis and management. Early detection can significantly impact treatment outcomes and quality of life for individuals with ATLD.
Ready to schedule your genetic test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Take the first step toward definitive neurological diagnosis and personalized care.
